Blue Water Acquisition III Unit. (BLUWU) vs Calidi Biotherapeutics (CLDI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BLUWU | CLDI |
|---|---|---|
| Share price | $10.42 | $0.4775 |
| Market cap | — | $1.65M |
| 1-day change | 0.00% | -5.45% |
| YTD return | -1.23% | — |
| EPS (TTM) | — | $-36.47 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $4.67M | $-19.91M |
| 52-week high | $12.85 | $24.80 |
| 52-week low | $0.00 | $0.465 |
| Distance from 52-week high | -18.91% | -98.07% |
| Average volume | 45 | 100.08K |
| Shares outstanding | — | 3.45M |
| Employees | — | 29 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Blue Water Acquisition III Unit.
BLUWU stock →Blue Water Acquisition Corp. III does not have significant operations.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
About Calidi Biotherapeutics
CLDI stock →Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck cancer, and sarcoma; and CLD-401 for the treatment of metastatic solid tumors.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 29 employees
BLUWU vs CLDI FAQ
Are Blue Water Acquisition III Unit. and Calidi Biotherapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.